Specify a stock or a cryptocurrency in the search bar to get a summary
Protagenic Therapeutics
PTIXProtagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York. Address: 149 Fifth Avenue, New York, NY, United States, 10010
Analytics
WallStreet Target Price
4 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures PTIX
Dividend Analytics PTIX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PTIX
Stock Valuation PTIX
Financials PTIX
Results | 2019 | Dynamics |